CLEAVE THERAPEUTICS

cleave-therapeutics-logo

Cleave Therapeutics develops oncology pharmaceuticals designed to target neurodengeneration and pathways used by cancer cells to grow. The company is engaged in the discovery of novel, small-molecule drugs that affect protein-degradation pathways, upon which cancer cells depend for survival, enabling patients to get cured from cancer.

#SimilarOrganizations #People #Financial #Website #More

CLEAVE THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Health Care

Founded:
2010-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.cleavetherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
(415) 562-8117

Email Addresses:
[email protected]

Total Funding:
89.95 M USD

Technology used in webpage:
SPF SSL By Default Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail Google Maps Microsoft Azure DNS GoDaddy DNS GStatic Google Static Content


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.


Current Advisors List

alfred-scheidegger_image

Alfred Scheidegger Board of directors @ Cleave Therapeutics
Board_member

jonathan-root_image

Jonathan Root Board of Directors @ Cleave Therapeutics
Board_member

carol-gallagher_image

Carol Gallagher Board of directors @ Cleave Therapeutics
Board_member

julian-adams_image

Julian Adams Member of the Scientific Advisory Board @ Cleave Therapeutics
Advisor

peter-thompson_image

Peter Thompson Board of Directors @ Cleave Therapeutics
Board_member

kush-parmar_image

Kush Parmar Board Observer @ Cleave Therapeutics
Board_observer
2011-01-01

not_available_image

Lewis Shuster Board of Directors @ Cleave Therapeutics
Board_member

laura-shawver_image

Laura Shawver Board Chair @ Cleave Therapeutics
Board_member
2011-01-01

Current Employees Featured

amy-burroughs_image

Amy Burroughs
Amy Burroughs President & CEO @ Cleave Therapeutics
President & CEO
2019-04-01

kerry-kelly_image

Kerry Kelly
Kerry Kelly Consultant @ Cleave Therapeutics
Consultant
2018-01-01

gregory-wilson_image

Gregory Wilson
Gregory Wilson Consulting CFO @ Cleave Therapeutics
Consulting CFO
2018-03-01

peter-thompson_image

Peter Thompson
Peter Thompson Co-Founder @ Cleave Therapeutics
Co-Founder
2010-01-01

jesse-vargas_image

Jesse Vargas
Jesse Vargas Head of Biology @ Cleave Therapeutics
Head of Biology
2018-01-01

not_available_image

Scott Harris
Scott Harris Chief Operating Officer @ Cleave Therapeutics
Chief Operating Officer
2019-07-01

Founder


peter-thompson_image

Peter Thompson

ray-deshaies_image

Ray Deshaies

Investors List

astellas-venture-management_image

Astellas Venture Management

Astellas Venture Management investment in Series C - Cleave Therapeutics

celgene_image

Celgene

Celgene investment in Series C - Cleave Therapeutics

osage-university-partners_image

OUP (Osage University Partners)

OUP (Osage University Partners) investment in Series C - Cleave Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Cleave Therapeutics

5am-ventures_image

5AM Ventures

5AM Ventures investment in Series C - Cleave Therapeutics

us-venture-partners_image

U.S. Venture Partners

U.S. Venture Partners investment in Series C - Cleave Therapeutics

venture-capital_image

Arcus Ventures

Arcus Ventures investment in Series C - Cleave Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series B - Cleave Therapeutics

astellas-venture-management_image

Astellas Venture Management

Astellas Venture Management investment in Series B - Cleave Therapeutics

clarus-ventures_image

Clarus Ventures

Clarus Ventures investment in Series B - Cleave Therapeutics

Official Site Inspections

http://www.cleavetherapeutics.com

  • Host name: 85.119.180.107.host.secureserver.net
  • IP address: 107.180.119.85
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Cleave Therapeutics" on Search Engine